These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1445501)
21. Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity. Dhanasekaran M; Albano CB; Pellet L; Karuppagounder SS; Uthayathas S; Suppiramaniam V; Brown-Borg H; Ebadi M Neurochem Res; 2008 Jun; 33(6):980-4. PubMed ID: 17768676 [TBL] [Abstract][Full Text] [Related]
22. Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. Maggio R; Riva M; Vaglini F; Fornai F; Racagni G; Corsini GU J Neural Transm (Vienna); 1997; 104(10):1113-23. PubMed ID: 9503263 [TBL] [Abstract][Full Text] [Related]
23. Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity by the antioxidant ascorbic acid. Sershen H; Reith ME; Hashim A; Lajtha A Neuropharmacology; 1985 Dec; 24(12):1257-9. PubMed ID: 3879338 [TBL] [Abstract][Full Text] [Related]
24. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility. Hofele K; Sedelis M; Auburger GW; Morgan S; Huston JP; Schwarting RK Exp Neurol; 2001 Mar; 168(1):116-22. PubMed ID: 11170726 [TBL] [Abstract][Full Text] [Related]
25. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium. Miller DB; Reinhard JF; Daniels AJ; O'Callaghan JP J Neurochem; 1991 Aug; 57(2):541-9. PubMed ID: 1649252 [TBL] [Abstract][Full Text] [Related]
26. [The effect of prolyl-leucyl-glycine (MIF-1) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine levels of the striatum]. Sheng JG Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug; 22(4):213-5, 253. PubMed ID: 2575971 [TBL] [Abstract][Full Text] [Related]
27. Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. Dluzen D; Jain R; Liu B J Neurochem; 1994 Jan; 62(1):94-101. PubMed ID: 8263548 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. Schulz JB; Matthews RT; Muqit MM; Browne SE; Beal MF J Neurochem; 1995 Feb; 64(2):936-9. PubMed ID: 7530297 [TBL] [Abstract][Full Text] [Related]
30. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice. Shepherd KR; Lee ES; Schmued L; Jiao Y; Ali SF; Oriaku ET; Lamango NS; Soliman KF; Charlton CG Pharmacol Biochem Behav; 2006 Mar; 83(3):349-59. PubMed ID: 16580056 [TBL] [Abstract][Full Text] [Related]
31. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization. Shen YQ; Hebert G; Lin LY; Luo YL; Moze E; Li KS; Neveu PJ J Neuroimmunol; 2005 Jan; 158(1-2):14-25. PubMed ID: 15589033 [TBL] [Abstract][Full Text] [Related]
32. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide. Cosi C; Marien M Brain Res; 1998 Oct; 809(1):58-67. PubMed ID: 9795136 [TBL] [Abstract][Full Text] [Related]
33. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice. Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929 [TBL] [Abstract][Full Text] [Related]
34. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress. Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333 [TBL] [Abstract][Full Text] [Related]
35. Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies. Harik SI; Riachi NJ; Hritz MA; Berridge MS; Sayre LM J Pharmacol Exp Ther; 1993 Aug; 266(2):790-5. PubMed ID: 8355208 [TBL] [Abstract][Full Text] [Related]
36. Pain perception in acute model mice of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Park J; Lim CS; Seo H; Park CA; Zhuo M; Kaang BK; Lee K Mol Pain; 2015 May; 11():28. PubMed ID: 25981600 [TBL] [Abstract][Full Text] [Related]
37. Nicotine administration reduces striatal MPP+ levels in mice. Quik M; Di Monte DA Brain Res; 2001 Nov; 917(2):219-24. PubMed ID: 11640907 [TBL] [Abstract][Full Text] [Related]
38. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains. Haobam R; Sindhu KM; Chandra G; Mohanakumar KP Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598 [TBL] [Abstract][Full Text] [Related]
39. Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. Janson AM; Fuxe K; Sundström E; Agnati LF; Goldstein M Acta Physiol Scand; 1988 Apr; 132(4):589-91. PubMed ID: 3265840 [No Abstract] [Full Text] [Related]
40. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice. Koga K; Mori A; Ohashi S; Kurihara N; Kitagawa H; Ishikawa M; Mitsumoto Y; Nakai M Eur J Neurosci; 2006 Feb; 23(4):1077-81. PubMed ID: 16519673 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]